Cell-specific gene expression programs are established during embryogenesis through transient environmental signals. These programs are then stably maintained and passed to daughter cells through a process of cellular memory. Experiments in Drosophila melanogaster have identified PcG and TrxG proteins as the mediators of this memory 1 . The list of genes that fall into PcG and TrxG protein groups is extensive 1, 2 , but those of known function are modifiers of chromatin structure: histone methyltransferases, ubiquitin E3 ligases and ATP-dependent chromatin-remodeling factors. This suggests that epigenetic modification of chromatin is important in establishing cellular memory.
PcG and TrxG proteins act antagonistically to establish and maintain tissue-specific patterns of gene expression, the former marking genes for repression whereas the later marks genes for expression. This is accomplished in part through trimethylation of histone H3 at Lys9 (H3K9me3) and/or Lys27 (H3K27me3) for repressed genes, and through the H3K4me3 modification for active genes 1, 3 . Indeed, studies based on chromatin immunoprecipitation (ChIP) coupled to DNA microarray analysis (ChIP-chip experiments) have suggested that developmentally regulated genes that are actively expressed are enriched for the H3K4me3 epigenetic mark in the 5¢ ends of their coding sequences 4 . The H3K27me3 and H3K9me3 modifications are enriched in facultative and constitutive heterochromatin, respectively 5 . Repression of transcription by PcG proteins is thought to be the default state, as these proteins can be found at both active and inactive genes, whereas TrxG proteins seem to be specifically targeted to active genes 6 . In agreement with this, loss of TrxG function prevents the expression of developmentally regulated genes 7 . In contrast, double mutations, where both a PcG protein (Ez) and a TrxG protein (Ash1) are mutated, result in ectopic expression of the developmentally regulated Hox genes 8 . This suggests that TrxG proteins act as antirepressors to ensure that PcG proteins do not repress expression of developmentally important genes in specific tissues.
During myogenesis, the Mef 2 family of MADS-box transcription factors and the muscle-specific transactivator MyoD target specific promoters 9 to establish a precise gene expression program, ultimately resulting in the formation of multinucleated myotubes. This myogenic gene expression program is temporally ordered 10 and is proposed to be mediated through a feed-forward mechanism 11 . Among the cofactors feeding into the myogenic program is the p38 mitogenactivated protein kinase (MAPK) 11 , which is crucial in establishing the muscle-specific gene expression program [10] [11] [12] [13] .
Although several important factors responsible for establishing muscle-specific gene expression have been identified, the mechanism by which transcription is activated at muscle-specific loci has remained elusive. Some insight has come from studies demonstrating that several muscle-specific genes are epigenetically marked for repression (by H3K27me3 or H3K9me3) in growing myoblasts 14, 15 . In the case of H3K27me3-marked genes, it has been shown that the transcriptional regulator YY1 targets the PcG protein Ezh2 to promoters 14 .
The fact that muscle-specific genes are targeted for repression by PcG proteins suggests that activation of these genes should require the antirepressive function of TrxG proteins. We set out to determine whether muscle-specific genes are epigenetically marked for gene expression in differentiating mouse C2C12 myoblasts, and if so, how TrxG proteins are targeted to these promoters.
RESULTS
Specific genes are marked for expression during myogenesis It has been proposed that genes poised for transcription are marked by H3K4me2, whereas those actively transcribing are marked by H3K4me3 (refs. 4,16) . Here we set out to examine whether genes that are expressed during myogenesis are marked by H3K4me3 during the transactivation process. The mouse C2C12 myoblast cell line was used as a model for these studies, as it can be induced to undergo myogenesis under conditions of serum withdrawal 17 . To avoid potential epitope masking by proteins that bind modified histone tails, we used a native ChIP protocol to immunoprecipitate nucleosomes with an H3K4me3-specific antibody. Using hydrolysis probes for quantitative PCR (qPCR) that recognized the 5¢ ends of the genes, we found that both the Myog and Ckm genes became enriched in nucleosomes containing H3K4me3 during C2C12 cell differentiation (Fig. 1a) . This enrichment coincided temporally with the increased expression of these two genes during myogenesis (Fig. 1b,c) . Consistent with previous results suggesting that not all active genes are enriched for the H3K4me3 mark 18 , we did not observe extensive enrichment of this mark in the transcribed Acta1 gene (Fig. 1a,b) . Similarly, no enrichment of H3K4me3 was observed at the Cdkn1a gene, which is transcribed before differentiation and whose expression is further upregulated during myogenesis, nor was there enrichment at the transcriptionally silent Igh locus (Fig. 1a,b) . Expanding our analysis to examine the distribution of H3K4me2 and H3K4me3 epigenetic marks across the Myog gene during C2C12 differentiation, we observed that the promoter region is enriched for the H3K4me2 mark, whereas the H3K4me3 mark peaks within the transcribed region of the gene ( Supplementary Fig. 1 online).
Ash2L associates with Mef 2d
Recent studies have suggested that the Ash2L protein is required for H3K4me3 to occur at specific loci 19, 20 . As Ash2L is expressed in both skeletal muscle 21 and C2C12 cells (Supplementary Fig. 2a online) , we examined whether Ash2L-containing complexes may be recruited to muscle-specific genes by developmentally regulated transcriptional activators. To identify candidate transcriptional activators that mediate recruitment of TrxG proteins, we turned to the Myog promoter. In this promoter, DNA binding elements responsible for establishing cellular memory should lie in a fragment of DNA containing the region between positions -184 and +18 relative to the Myog transcription start site, as this region is sufficient to ensure muscle-specific expression of the gene 22, 23 . As Myog has a well-characterized promoter [22] [23] [24] [25] [26] , we looked for interactions between Ash2L and transcriptional activators known to bind this region. Western blotting analysis of proteins co-immunoprecipitating with Ash2L indicated the presence of Mef 2 but not the muscle-specific transcriptional activators MyoD or myogenin (Fig. 2a) . In a reciprocal experiment, immunoprecipitation of Mef 2 with a pan-Mef 2 antibody confirmed the interaction between the transcriptional activator and the Ash2L complex subunits Ash2L, RbBP5 and menin, along with the methyltransferase MLL2 (Fig. 2b) . Furthermore, methyltransferase assays performed with Mef 2 immunoprecipitates confirmed that the transcriptional activator associates with an H3K4 methyltransferase activity in differentiating C2C12 cell extracts ( Supplementary  Fig. 2c,d) . Notably, the association between Ash2L and Mef 2 was not observed in undifferentiated C2C12 cells or at the early stages of differentiation (data not shown), suggesting that the interaction between these proteins may be developmentally regulated. As Ash2L is present in at least five known methyltransferase complexes 27 , we examined whether the interaction between Ash2L and Mef 2 is limited to MLL2-containing complexes. Using antibodies directed against various H3K4 methyltransferases, we were able to immunoprecipitate Mef 2 with antibodies to MLL2, Set1 and MLL3, but not MLL or MLL4 ( Supplementary Fig. 2b ). Thus, Mef 2 can interact with several Ash2L complexes, but it preferentially interacts with MLL2-containing complexes.
To determine whether Mef 2 recruits the Ash2L complex to mediate H3K4 trimethylation on muscle-specific genes, we used ChIP analysis to measure the binding of these two factors to the Myog and Ckm promoters during C2C12 differentiation. Consistent with an association between Mef 2 and the Ash2L complex, we observed a good correlation of their recruitment to the Ckm promoter (Fig. 2c) . In contrast, the recruitment of Ash2L did not coincide temporally with the recruitment of Mef 2 at the Myog gene. Instead, Mef 2 was recruited to the Myog promoter within 6 h after serum withdrawal, whereas recruitment of Ash2L, marking of nucleosomes by H3K4me3 and gene activation were maximal at later stages (48 h) in the differentiation process ( Fig. 1 and Fig. 2c ). Thus, recruitment of Ash2L is temporally distinct from that of Mef 2 at the Myog promoter.
Phosphorylation of Mef 2d permits association with Ash2L
As our antibody recognizes all four Mef 2 isotypes (Mef 2a, Mef 2b, Mef 2c and Mef 2d), one possibility is that Ash2L interacts with a specific Mef 2 isotype whose expression or activity changes during differentiation. To test this possibility, we studied interactions between Ash2L and the three Mef 2 isotypes that are known to be expressed in muscle. Baculoviruses encoding C-terminally Flag-tagged Mef 2a (FL-Mef 2a), Mef 2c (FL-Mef 2c) and Mef 2d (FL-Mef 2d) were engineered. Recombinant Mef 2 proteins were then purified from baculovirus-infected Sf 9 cell extracts using M2-Flag agarose beads. As phosphorylation has been proposed to activate Mef2 gene products 28 , the different purified Mef 2 proteins were incubated in the presence (or absence) of active p38a MAPK 29 before incubation with an extract prepared from differentiating (48 h) C2C12 cells. Although Ash2L did not bind FL-Mef 2a, we consistently observed an interaction with FL-Mef 2d (Fig. 3a) . Notably, this interaction was enhanced when FL-Mef 2d was phosphorylated by p38a. A weaker interaction between p38a-treated FL-Mef 2c and Ash2L could also be seen. Thus, Ash2L seems to associate selectively with the phosphorylated Mef 2d isotype (and, to a lesser extent, with phosphorylated Mef 2c). It is not clear why Mef 2a does not also interact with Ash2L. However, it is not a case of differential b-exon usage, as all three constructs contained the previously described isoform-specific acidic transactivation domain 30 .
We did observe some interaction between Ash2L and Mef 2d in the absence of exogenous p38a. This is probably due to the presence of endogenous p38 activity present in the C2C12 cell extracts.
To examine the importance of Mef 2d phosphorylation by p38a in mediating its interaction with Ash2L, we generated a Mef 2d construct with mutated consensus p38 phosphorylation sites (T308A T315A). These mutations greatly reduced in vitro phosphorylation of the Mef 2d protein by p38a ( Fig. 3b) and completely blocked its interaction with Ash2L (Fig. 3c) . Furthermore, this protein behaved as a dominant-negative mutant, leading to decreased expression of the endogenous Myog gene in transfected C2C12 cells (Supplementary Fig. 3 online) . To further confirm that p38-dependent phosphorylation of Mef 2d regulates its interaction with Ash2L, we immunoprecipitated Mef 2 from extracts of C2C12 cells that had been differentiated in the presence or absence of the p38 MAPK inhibitor SB203580. Use of this p38a/b-specific kinase inhibitor has previously been demonstrated to block phosphorylation of Mef 2 proteins in differentiating L8 myoblasts 13 . As expected, treatment of C2C12 cells with SB203580 markedly reduced the amount of Ash2L that coimmunoprecipitated with Mef 2 (Fig. 3d) . These results suggest that Ash2L interacts with phosphorylated Mef 2d.
As the interaction between Ash2L and Mef 2d was not observed in growing myoblasts, we examined whether expression of the transcriptional activator is upregulated during C2C12 cell differentiation. However, both semiquantitative reverse-transcription (RT)-PCR and western blotting analysis showed that Mef 2d levels remained relatively constant throughout C2C12 differentiation ( Supplementary  Fig. 4 online) . Therefore, we next examined whether p38 MAPK activity varies during C2C12 differentiation. In accordance with previous reports 12 , we found that levels of total p38 remained constant throughout differentiation. In contrast, there was markedly more active (phosphorylated) p38 during differentiation, with the maximal amount attained 48 h after serum withdrawal ( Supplementary  Fig. 4b ). Thus, our results suggest that Mef 2d recruits Ash2L to muscle-specific promoters in a p38-dependent manner.
p38 regulates recruitment of Ash2L to muscle-specific promoters To examine this possibility in vivo, we performed ChIP experiments with C2C12 cells that had been differentiated in the presence of SB203580. Treatment of C2C12 cells with SB203580 did not affect total p38 levels in the cell (Fig. 4a) . As previously observed 31 , expression of both Ckm and Myog in differentiating C2C12 was inhibited by SB203580 treatment (Fig. 4b) . This is not a global effect on transcription, as expression of Acta1, Mef 2c and Mef 2d was not affected. Furthermore, ChIP experiments demonstrated that the block in transcription at the Myog and Ckm genes was not due to reduced recruitment of MyoD, Mef 2, p300 or RNA polymerase II (Pol II) to these loci ( Fig. 4c and Supplementary Fig. 5 online) . Similarly, acetylation of histone H4 (H4ac) was not affected by SB203580 treatment, suggesting that the promoters are poised for transcription. Treatment of differentiating C2C12 cells with SB203580 did, however, substantially decrease Ash2L recruitment and H3K4me3 at both of these muscle-specific promoters ( Fig. 4c and Supplementary Fig. 5 ). This shows that p38 kinase activity is required in vivo for efficient recruitment of the Ash2L complex and H3K4 trimethylation at the Myog and Ckm promoters.
To confirm that Ash2L is recruited to the muscle-specific promoters through an Mef 2-dependent mechanism, we used short interfering RNA (siRNA)-mediated knockdown of Mef 2d and Mef 2c in C2C12 cells. Whereas the knockdowns did not appreciably affect Acta1 expression, both Myog and Ckm genes were markedly downregulated in response to knockdown of Mef 2d or Mef 2c (Fig. 5a,b) . Because both Mef 2c and Mef 2d are required for maximal transactivation of the Ckm and Myog genes (Fig. 5b) , we decided to knock down both Mef 2 isotypes in the same population of C2C12 cells for ChIP studies (Fig. 5c,d ). Analysis of promoter occupancy at both the Ckm and Myog genes revealed that the siRNA treatment reduced recruitment of Mef 2 during differentiation by 80%, whereas MyoD levels remained constant ( Fig. 5d and Supplementary Fig. 6 online). Loss of Mef 2 binding at these promoters coincided with decreased H3K4me3 and a concomitant increase in H3K4 dimethylation ( Fig. 5c and Supplementary Fig. 6 ). Similarly, knockdown of Mef 2d markedly decreased recruitment of both Ash2L and MLL2 to the Myog and Ckm promoters ( Fig. 5d and Supplementary Fig. 6 ). Our observation that Ash2L binding was reduced by only 50% when Mef 2 binding was reduced by 80% is probably explained by the ability of the TrxG complex to interact with multiple elements in the promoter region, including CBP/p300 (ref. 32) , unmethylated CpG dinucleotides 33 and H3K4me2 (ref. 34 ). Thus, although phosphorylated Mef 2d is probably required for initial recruitment of Ash2L, the increased affinity accorded by multiple interactions at the promoter might further stabilize the binding of the Ash2L complex. Lastly, to confirm the importance of the Ash2L complex in regulating gene expression at muscle-specific loci, we examined the effect of siRNA knockdown of Ash2L in C2C12 cells. Indeed, reduced levels of Ash2L in C2C12 cells (Fig. 6a) led to decreased expression of both the Myog and Ckm genes while having no effect on Acta1 RNA levels during muscle differentiation (Fig. 6b) . This decreased expression can be correlated with reduced recruitment of Ash2L and less H3K4me3 at the Myog gene (Fig. 6c) and Ckm gene (data not shown). Thus, our studies reveal that establishment of the H3K4me3 mark at the Myog and Ckm promoters during muscle differentiation occurs through a series of ordered events involving Mef 2d phosphorylation by p38 MAPK and subsequent recruitment of the Ash2L methyltransferase complex.
DISCUSSION
In this study, we show that Ash2L is recruited to muscle-specific promoters through its association with the transcriptional activator Mef 2d. Furthermore, we demonstrate that Ash2L recruitment is regulated via phosphorylation of Mef 2d by the p38 MAPK. Indeed, we observed Mef 2 recruitment to the Myog promoter early in differentiation, whereas Ash2L was not recruited until p38 activity became upregulated during later stages of differentiation. Notably, Ash2L showed different affinities for the various members of the Mef 2 family of transcriptional activators. Combined with our observation that continued expression of Mef 2a in Mef 2d-and Mef 2c-knockdown cells did not allow expression of the Myog and Ckm genes, these results demonstrate that the Mef 2 isotypes have different functions during myogenesis. In particular, we show that Mef 2d integrates the p38 MAPK signaling pathway to establish the epigenetic H3K4me3 mark at muscle-specific promoters.
The essential role for the p38 MAPK signaling pathway in myogenesis has been well documented 35 . Treatment of myoblasts with SB203580 inhibits the formation of myotubes and blocks expression of a subset of muscle-specific genes [10] [11] [12] [13] . Many studies have demonstrated that factors involved in transcriptional regulation in muscle are targets for phosphorylation by p38, including Mef 2a and Mef 2c 28 as well as Mef 2d 11 . Furthermore, phosphorylation of the Mef 2 activation domains by p38 has been shown to markedly increase its ability to activate transcription 28 . Finally, it has been demonstrated that precocious activation of p38 in the presence of Mef 2d leads to altered Figure 7 Model for the integration of the p38 MAPK signaling pathway with Mef2-dependent recruitment of the Ash2L complex to muscle-specific promoters. Before activation of p38, MyoD and E47 (MD/E) cooperate with Mef2d dimers (homo-or heterodimers) to establish a transcriptionally poised promoter through recruitment of the acetyltransferase p300 and Pol II. This leads to acetylation of nucleosomes on histone H4 within the promoter. As differentiation proceeds, cell-cell contact activates the membrane-bound receptor Cdo, leading to p38 MAPK activation via the scaffold protein JLP and the MKK6 kinase 36 . Once activated, p38 MAPK phosphorylates Mef2d, leading to targeting of the Ash2L methyltransferase complex to musclespecific promoters. The methyltransferase complex then establishes the epigenetic H3K4me3 mark required for abundant expression of developmentally regulated genes.
kinetics of transcription during myogenesis such that ordinarily late-expressing genes are expressed during the early stages of differentiation 11 . Although these observations have suggested that p38-dependent phosphorylation of Mef 2 proteins might be involved in establishing muscle-specific patterns of gene expression, the function of phosphorylation of the Mef 2 activation domain has not previously been defined. Our study shows that the Ash2L methyltransferase complex is selectively recruited to muscle-specific promoters through p38-dependent phosphorylation of Mef 2d, providing insight into the regulation of muscle-specific transcription by MAPK signaling. On the basis of the results obtained in this study, we propose a model for Mef 2d-dependent activation of muscle-specific genes during myogenesis (Fig. 7) . During differentiation, MyoD and Mef 2 bind muscle-specific promoters, leading to the recruitment of coactivators (including p300) and the basal transcriptional machinery to establish a transcriptionally poised promoter. Consistent with previous observations 31 , we detected Pol II and the acetyltransferase p300 at the Myog and Ckm promoters in the absence of p38 activity. This results in a promoter that contains H4ac. Once the muscle-specific genes are poised for transcription, their expression is initiated through activation of the p38 MAPK pathway. Recent studies have suggested that prolonged activation of the p38 MAPK pathway could be mediated through activation of the membrane-bound receptor Cdo as a result of cell-cell contact 36 . Once activated, p38 can then phosphorylate Mef 2d, thereby permitting the recruitment of the Ash2L complex to muscle-specific promoters, which ultimately would lead to trimethylation of H3K4. Combined with the p38-dependent remodeling of nucleosomes in the promoter region by the ATP-dependent chromatinremodeling complex SWI/SNF 31 , the H3K4me3 modification would permit abundant expression of developmentally regulated genes. Notably, our siRNA experiments demonstrate that a decrease in H3K4me3 is matched by an increase in H3K4me2 ( Fig. 5c and Supplementary Fig. 6 ), suggesting that these two modifications exist in a dynamic equilibrium that may allow rapid conversion from a poised promoter to an actively transcribing gene. The p38 MAPK pathway has previously been shown to be essential for the recruitment of SWI/SNF to the Myog and Ckm promoters 31 . This is particularly noteworthy because the catalytic subunits of SWI/ SNF (BRM/BRG1) are in the same TrxG family of proteins as Ash2L 1,2 . Furthermore, it has been shown that Mef 2d cooperates with myogenin to recruit SWI/SNF to the promoter region of the Ckm gene 37 . In contrast, several studies have suggested that SWI/SNF is recruited to the Myog promoter through an interaction with MyoD 31, 38 in the absence of Mef 2 (ref. 31) . Whereas SWI/SNF seems to be recruited to the Myog and Ckm promoters through different mechanisms, we observed Mef 2d-and p38-dependent recruitment of Ash2L to both Myog and Ckm. Thus, there seems to be some difference in the mechanism by which Ash2L and SWI/SNF are targeted to developmentally regulated genes. However, p38 regulates the recruitment of both these TrxG complexes to specific genes ( Fig. 4c and ref. 31) . We propose that one of the mechanisms by which p38 promotes myogenesis is through targeting of TrxG proteins to muscle-specific genes to establish tissue-specific expression.
In conclusion, we show here that muscle-specific genes do become epigenetically marked for gene expression during myogenesis. Targeting of the H3K4me3 mark to specific promoters is mediated by the Ash2L methyltransferase complex, which is recruited by the DNAbound transcriptional activator Mef 2d. Furthermore, we find that this recruitment is regulated through the p38 MAPK-mediated phosphorylation of Mef 2d, which enhances the association between the transactivator and the methyltransferase complex. Thus, our study mechanistically links the p38 MAPK signaling pathway with the activation of muscle-specific genes during myogenesis.
METHODS
Antibodies. We used antibodies specific to H3K4me3 (Abcam ab8580), H3K4me2 (Upstate 07-030), H4ac (Upstate 06-866), WDR5 (Abcam ab22512), RbBP5 (Bethyl BL766), Mef 2 (Santa Cruz sc-17785, sc-13917), Mef 2d (BD Biosciences 610774), Set1 (Bethyl A300-289A), MLL (Bethyl A300-087A), MLL2/Trx2 (Bethyl A300-113A), menin (Bethyl A300-105A), Pol II (Santa Cruz sc-17798, sc-9001, sc-5943), p300 (Santa Cruz sc-584), p38 (Santa Cruz sc-7972), p38 phosphorylated on Thr180 and Tyr182 (Cell Signaling 9211S), myogenin (Developmental Studies Hybridoma Bank F5D) and Flag (Sigma F-3165). Antibodies to MLL3 and MLL4/ALR have been described 27 . Antibodies against MyoD, Ash2L, DPY30 were raised in rabbits using purified full-length proteins.
Cell culture. The mouse myoblast cell line C2C12 (ref. 17 ) was maintained at less than 80% confluency in DMEM containing 10% (v/v) FBS, L-glutamine, penicillin and streptomycin. For differentiation studies, cells were washed with PBS when they attained 80% confluence and then incubated in differentiation medium (DMEM containing 2% (v/v) horse serum, 10 mg ml -1 insulin, 10 mg ml -1 transferrin, L-glutamine, penicillin and streptomycin) for 48 h (unless otherwise noted). Control siRNAs or siRNAs targeting Mef 2c, Mef 2d or Ash2l (Ambion) were transfected at a final concentration of 100 nM using Lipofectamine 2000 (Invitrogen) and transferred to differentiation media immediately. For p38 MAPK inhibition studies, SB203580 was added directly to the differentiation media at a final concentration of 10 mM.
Native chromatin immunoprecipitation. Approximately 1 Â 10 7 C2C12 cells obtained at various stages of differentiation were lysed in buffer A (15 mM Tris (pH 7.5), 15 mM NaCl, 60 mM KCl, 250 mM sucrose, 5 mM MgCl 2 , 1.5 mM CaCl 2 , 1 mM DTT and 1 mM PMSF). Nuclei were recovered by centrifugation and quantified by measuring total ribonucleic acid content. Chromatin (15 mg) was digested with 1 U MNase (Sigma) for 10 min at 37 1C to give a maximum visible fragment size of 550 base pairs (three nucleosomes). NaCl was then added to a final concentration of 600 mM, and the nuclei were incubated with 10 mg of hydroxyapatite resin to generate a slurry. After extensive washing, nucleosomes were eluted from the resin with a buffer containing 300 mM NaPO 4 (pH 7.2). Eluted nucleosomes were then subjected to immunoprecipitation with either an anti-H3K4me3, anti-H3K4me2 or control rabbit IgG, as described in the figure legends. Immunoprecipitated DNA was purified and subjected to qPCR analysis with hydrolysis probes (see Supplementary Table 1 online for primer and probe sequences). To calculate relative enrichment, we subtracted the signal observed in the control immunoprecipitation experiment from that observed with the specific antibody, then divided the resulting difference by the signal observed from one-fiftieth of the ChIP input material.
Chromatin immunoprecipitation. ChIP assays were done as described 39 , except that DNA was sonicated using a bioruptor to obtain fragments approximately 400 base pairs in length. Immunoprecipitated DNA was reverse-cross-linked, purified and subjected to qPCR analysis with hydrolysis probes (see Supplementary Table 1 for primer and probe sequences). Relative enrichment was calculated as described for native ChIP studies. and Mef 2da1,b (FL-MEf 2D) were expressed using baculovirus in Sf 9 cells and purified with anti-Flag M2-agarose beads (Sigma). The phosphorylationdeficient mutant of Mef 2d was generated by mutation of both Thr308 and Thr315 to alanine using the QuikChange system (Stratagene). Activated p38a was purified from a BL-21 strain stably coexpressing His-p38a, MEK4 and MEKK-C 29 with nickel-nitrilotriacetic acid (Ni-NTA) resin (Qiagen).
Immunoprecipitation and Flag pull-down assays. Cell extracts were prepared in lysis buffer (50 mM Tris (pH 8.0), 150 mM NaCl, 1% (v/v) Nonidet P-40, 0.1% (w/v) SDS, 0.5% (v/v) sodium deoxycholate and Complete protease inhibitors (GE Healthcare)) from differentiating C2C12 cells at the 48 h time point. Either protein A or protein G Dynabeads were coated with antibodies as described 39 . Approximately 400 mg of protein lysate were subjected to immunoprecipitation with various antibodies (as indicated in figure legends). Beads were then washed three times with buffer containing 300 mM KCl and 0.1% (v/v) Nonidet P-40, and proteins were eluted in SDS loading dye and then subjected to western blotting.
For Flag pull-down assays, extracts prepared from baculovirus-infected Sf 9 cells expressing recombinant proteins of interest were incubated with Flag M2-Agarose beads for 1 h. The beads were then washed with EX-100 buffer 40 to remove unbound proteins. For phosphorylation experiments, protein-bound beads were incubated in the presence of 1 mM ATP with or without p38a kinase for 30 min at 30 1C. After washing to remove ATP and p38a, beads were incubated with 48 h-differentiated C2C12 cell extract. Interacting proteins were eluted in SDS loading dye and subjected to western blotting with indicated antibodies.
Reverse-transcription PCR assays. Total RNA (3 mg) was reverse-transcribed with MuMLV reverse transcriptase. The resulting random primed complementary DNA was subjected to semiquantitative RT-PCR with gene-specific primers (see Supplementary Table 1 for primer sequences) for Myog, Ckm, Cdkn1a, Acta1, Mef 2a, Mef 2c, Mef 2d and Actb (encoding b-actin). For quantitative RT-PCR (qRT-PCR), duplex reactions were performed using 6-fluorescein phosphoramidite (FAM)-labeled and 3¢ black hole quencher-1 (BHQ)-labeled gene-specific primers (see Supplementary Table 1 for primer sequences) and 5¢ yakima yellow (YY)-labeled and 3¢ eclipse dark quencher (EDQ)-labeled primers specific for 18S ribosomal RNA (Eurogentec).
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
